No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
963 |
4. Check minimum number of eventsNone |
963 |
5. Include endpointsNone |
963 |
6. Filter based on genotype QC (FinnGen only) |
872 |
Control definitions (FinnGen only)
- Control exclude
- H7_CONJUNCTIVA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H11
- Name in latin
- Aliae morbositates vasculares et cystae conjunctivae
Similar endpoints
↥List of similar endpoints to
Other conjunctival vascular disorders and cysts
based on the number of shared cases.
Similar with more cases:
- Other disorders of conjunctiva
- Disorders of conjunctiva
- Diseases of the eye and adnexa
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5855 | 3365 | 2462 |
| Only index persons | 5436 | 3191 | 2245 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.07 |
| Only index persons | 0.10 | 0.12 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 55.86 | 55.85 | 55.92 |
| Only index persons | 55.47 | 55.40 | 55.57 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 872 | 564 | 308 |
| Unadjusted period prevalence (%) | 0.18 | 0.20 | 0.14 |
| Median age at first event (years) | 56.71 | 55.32 | 59.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 902
- Matched controls
- 9020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
4503599627370496.0
307.7
872
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
196.3
131.4
134
8
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
23.1
57.3
42
19
CBB30
NOMESCO Finland
Excision of lesion of eyelid
6.8
49.0
80
127
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.8
47.5
408
2082
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
44.7
499
2873
S01GX01
ATC
cromoglicic acid; ophthalmic
3.2
41.7
194
702
CFA20
NOMESCO Finland
Biopsy of conjunctiva
124.8
33.9
36
*
H04.10
ICD-10 Finland
Dry eye syndrome
3.1
31.9
155
570
F29
ICPC
Eye symptom/complaint other
2.9
25.3
134
514
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
3.7
22.0
74
215
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
8.3
21.9
29
36
H15.1
ICD-10 Finland
Episcleritis
7.2
21.3
32
46
H11.0
ICD-10 Finland
Pterygium
47.1
19.3
23
5
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
102.2
18.6
20
*
H11.3
ICD-10 Finland
Conjunctival haemorrhage
4.0
18.1
52
135
H00.1
ICD-10 Finland
Chalazion
3.8
17.1
54
150
37820
ICD-8 Finland
Other diseases of eye, Cysta conjunctivae
+∞
15.7
15
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
15.5
112
497
S01GX02
ATC
levocabastine; ophthalmic
3.5
15.4
53
156
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.5
15.1
52
153
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
14.7
188
1049
3727A
ICD-9 Finland
Disorders of conjunctiva, Conjunctival vascular disorders and cysts
+∞
14.6
14
*
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
+∞
14.6
14
*
127
Kela drug reimbursment
Transplant complication
5.8
14.2
26
46
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
13.8
224
1351
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.3
13.7
111
517
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.9
12.6
61
221
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
70.9
12.6
14
*
L04AD01
ATC
ciclosporin; systemic
5.1
12.5
26
52
H01.0
ICD-10 Finland
Blepharitis
2.6
12.4
72
288
H57.1
ICD-10 Finland
Ocular pain
3.3
12.2
46
144
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
12.2
333
2323
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
11.7
72
296
E0000UV, ,
ATC
1.6
11.6
369
2668
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
11.4
643
5355
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
11.4
181
1078
H10.4
ICD-10 Finland
Chronic conjunctivitis
35.5
11.3
14
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
9.8
11.3
22
23
M03BX02
ATC
tizanidine; oral
1.6
11.1
559
4506
L04AA06
ATC
mycophenolic acid; systemic
4.4
10.8
27
63
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
10.7
198
1233
XCK00
NOMESCO Finland
Perimetry
2.6
10.6
64
260
N03AX16
ATC
[U] pregabalin
1.7
10.6
217
1390
M25.5
ICD-10 Finland
Pain in joint
1.6
10.4
310
2191
SFA20
NOMESCO Finland
Two-surface restoration
1.6
10.2
519
4155
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
10.2
76
342
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
9.9
390
2936
R01AD12
ATC
fluticasone furoate; nasal
1.6
9.7
266
1837
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
9.6
635
5373
SFA10
NOMESCO Finland
One-surface restoration
1.6
9.5
490
3910
S01GX08
ATC
ketotifen; ophthalmic
3.5
9.4
32
94
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.8
9.3
45
164
J01DB01
ATC
cefalexin; oral
1.7
9.2
730
6421
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
9.2
363
2724
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
9.1
481
3842
S18
ICPC
Laceration/cut
1.5
9.1
436
3409
ZXA10
NOMESCO Finland
Bilateral
1.7
9.1
171
1066
D06
ICPC
Abdominal pain localized other
2.1
9.1
85
420
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
9.0
577
4805
S01BA04
ATC
prednisolone; ophthalmic
3.9
9.0
26
68
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
8.9
89
450
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
8.9
92
472
K02.1
ICD-10 Finland
Caries of dentine
1.5
8.9
509
4131
J05AB01
ATC
aciclovir; systemic
1.7
8.9
202
1326
S01GX09
ATC
olopatadine; ophthalmic
4.2
8.8
23
56
H15.0
ICD-10 Finland
Scleritis
27.8
8.5
11
*
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
8.6
8.3
17
20
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
8.2
202
1349
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
8.2
210
1418
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
8.1
72
348
CD2S4
NOMESCO Finland
Photography of eye
11.8
8.1
14
12
H02AB06
ATC
prednisolone; systemic
1.5
8.1
405
3174
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.6
8.0
268
1927
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.2
7.9
66
312
R06AE07
ATC
cetirizine; oral
1.5
7.9
363
2792
H02AB04
ATC
methylprednisolone; systemic
1.8
7.8
127
756
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.9
7.8
109
619
M01AE02
ATC
naproxen; oral, rectal
1.5
7.8
492
4027
A02BC02
ATC
pantoprazole; systemic
1.5
7.7
606
5182
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.0
7.6
85
449
S01GX06
ATC
emedastine; ophthalmic
10.1
7.5
14
14
XCH00
NOMESCO Finland
Eye pressure measurement
2.4
7.5
49
208
H00.00
ICD-10 Finland
Hordeolum
2.5
7.4
45
184
S01BC03
ATC
diclofenac; ophthalmic
3.5
7.4
25
73
Z94.0
ICD-10 Finland
Kidney transplant status
6.5
7.4
18
28
N02BE01
ATC
paracetamol; systemic, rectal
1.8
7.3
799
7324
J02AC01
ATC
fluconazole; systemic
1.5
7.3
335
2566
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
7.2
395
3129
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.2
259
1885
CF2S4
NOMESCO Finland
Photography of conjunctiva
30.3
7.2
9
*
CBA10
NOMESCO Finland
Biopsy of eyelid
5.7
7.1
19
34
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
8.9
7.1
14
16
J01FA10
ATC
azithromycin; systemic
1.5
7.0
478
3938
H10.5
ICD-10 Finland
Blepharoconjunctivitis
4.3
7.0
18
43
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
7.0
90
498
L03
ICPC
Low back symptom/complaint
1.5
6.9
255
1863
X58
ICD-10 Finland
Exposure to other specified factors
1.7
6.9
128
793
R00.2
ICD-10 Finland
Palpitations
2.0
6.9
75
393
D07AC01
ATC
betamethasone; topical
1.5
6.8
306
2323
S01GX05
ATC
lodoxamide; ophthalmic
9.4
6.8
13
14
R06AX27
ATC
desloratadine; oral
1.5
6.7
223
1591
M54.5
ICD-10 Finland
Low back pain
1.5
6.7
319
2450
A02BC05
ATC
esomeprazole; systemic
1.5
6.6
349
2730
S29
ICPC
Skin symptom/complaint other
1.6
6.6
178
1209
H02.3
ICD-10 Finland
Blepharochalasis
2.0
6.6
68
349
Z01.2
ICD-10 Finland
Dental examination
1.4
6.5
389
3113
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.5
365
2887
R21
ICPC
Throat symptom/complaint
1.6
6.5
164
1097
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.5
396
3180
L82
ICD-10 Finland
Seborrhoeic keratosis
1.6
6.5
175
1190
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.0
6.4
65
331
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.4
194
1356
SDA03
NOMESCO Finland
Periodontal treatment
1.4
6.4
344
2701
UJF32
NOMESCO Finland
Coloscopy
1.5
6.3
231
1678
H26.2
ICD-10 Finland
Complicated cataract
5.2
6.3
18
35
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.3
6.3
48
218
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.3
439
3606
F45.8
ICD-10 Finland
Other somatoform disorders
2.1
6.3
57
279
L04AX01
ATC
azathioprine; systemic
2.5
6.3
38
156
CFC15
NOMESCO Finland
Destruction of lesion of conjunctiva
+∞
6.3
6
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
6.3
6
*
M01AH01
ATC
celecoxib; oral
1.6
6.3
159
1066
F13
ICPC
Eye sensation abnormal
2.8
6.2
31
115
R60.0
ICD-10 Finland
Localized oedema
1.7
6.2
113
695
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
6.2
189
1323
KMAK, ,
NOMESCO Finland
1.4
6.1
419
3425
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
6.0
302
2332
UDC00
NOMESCO Finland
Ear microscopy
1.9
6.0
69
368
M48.0
ICD-10 Finland
Spinal stenosis
1.7
6.0
115
717
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
6.0
41
178
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
722
6255
1.77
10.58
9.9
8.3
75.74
79.97
u/l
2.21
687
5926
529
4353
1.52
8.48
5.1
4.0
0.00
0.02
estimate
1.46
112
868
520
4267
1.52
8.42
5.0
4.0
0.00
0.00
estimate
0.50
114
896
258
1848
1.55
7.77
3.3
2.7
4.10
6.08
e6/l
2.53
246
1696
521
4326
1.48
7.62
5.1
4.0
0.00
0.00
estimate
0.50
116
924
507
4216
1.46
7.16
8.2
7.1
1.22
1.21
mmol/l
0.84
434
3649
554
4696
1.47
7.02
10.6
9.8
4.03
4.07
e9/l
0.15
497
4099
456
3726
1.45
7.00
6.5
5.0
35.00
35.59
g/l
1.36
427
3510
112
665
1.78
6.96
2.9
2.7
58.86
65.27
ml/min/173m2
1.01
49
289
676
5970
1.53
6.93
5.9
4.5
10.94
12.60
mm/h
3.22
639
5566
405
3250
1.45
6.77
5.1
4.0
1.27
0.05
estimate
0.63
101
745
818
7581
1.85
6.76
5.9
5.3
5.91
5.96
mmol/l
0.58
748
6944
840
7852
2.02
6.76
6.5
6.0
2.73
2.71
mmol/l
0.29
773
7284
565
4834
1.45
6.62
5.7
5.0
6.58
6.69
mmol/l
0.67
542
4592
311
2391
1.46
6.44
5.8
4.1
0.00
0.01
estimate
1.15
111
840
803
7421
1.75
6.44
7.2
6.6
39.28
39.53
mmol/mol
0.34
742
6952
829
7734
1.89
6.43
20.6
16.2
21.00
23.92
mg/l
1.90
705
6336
373
2970
1.44
6.40
3.3
3.5
2.35
2.36
mmol/l
0.33
336
2704
796
7343
1.72
6.37
6.5
5.5
1.85
1.93
mu/l
0.99
733
6766
825
7700
1.84
6.17
5.6
5.2
1.52
1.49
mmol/l
1.12
755
7124
828
7739
1.85
6.13
5.7
5.3
4.69
4.66
mmol/l
0.36
766
7211
696
6249
1.50
5.99
5.4
4.4
14.88
14.83
pmol/l
0.19
632
5720
459
3833
1.40
5.83
15.3
14.7
1.23
1.24
inr
0.20
386
3170
792
7366
1.62
5.28
4.8
4.4
1.29
1.29
mmol/l
0.09
725
6754
450
3788
1.38
5.24
7.7
6.4
1.22
1.21
mmol/l
0.42
419
3501
334
2679
1.39
5.22
4.0
3.4
21.64
74.73
e6/l
1.42
277
2061
600
5298
1.40
5.17
5.9
4.8
49.78
2417.37
e6/l
—
9
79
107
684
1.64
5.09
4.5
3.6
90.91
83.79
ng/l
0.32
90
600
448
3791
1.36
4.94
3.5
3.0
124.28
127.18
ug/l
0.10
415
3517
842
7985
1.82
4.87
24.1
19.2
139.80
139.70
mmol/l
0.65
830
7815
843
7998
1.83
4.86
24.3
19.4
3.97
3.97
mmol/l
0.18
830
7814
148
1035
1.51
4.78
2.2
2.3
149.86
119.04
ug/g
0.45
116
821
248
1915
1.41
4.77
1.4
1.3
2.14
1.85
u/ml
0.09
70
523
270
2117
1.39
4.75
2.9
2.7
338.43
338.11
umol/l
0.02
242
1868
274
2159
1.39
4.66
2.7
2.3
2.97
2.89
mg/l
0.20
239
1860
382
3181
1.35
4.56
4.4
3.8
739.45
64.81
ng/l
0.46
270
2319
85
531
1.66
4.43
2.6
2.5
5.65
19.09
au/ml
—
6
47
179
1322
1.44
4.38
2.7
2.5
2.35
2.31
g/l
0.45
169
1225
317
2579
1.35
4.36
3.3
3.1
1463.54
1184.26
ng/l
0.50
271
2200
205
1553
1.41
4.36
1.4
1.3
156.66
30.92
iu/ml
0.45
53
504
16
51
3.18
4.22
2.2
2.5
—
—
—
0
0
78
483
1.67
4.21
1.3
1.4
48.14
51.15
au/ml
—
5
37
320
2619
1.34
4.20
2.4
2.1
152.92
237.44
u/l
1.73
301
2489
100
660
1.58
4.19
3.4
2.9
10.32
10.82
g/l
0.29
94
610
34
161
2.16
4.14
8.8
7.2
140.17
328.38
iu/ml
—
6
29
286
2308
1.35
4.10
3.6
3.3
0.30
0.42
e6/l
0.60
233
1697
84
534
1.63
4.10
1.5
1.3
472.36
251.06
u/ml
0.30
78
492
858
8236
1.86
3.99
27.4
21.4
78.01
76.31
umol/l
1.10
850
8137
217
1683
1.38
3.99
1.6
1.4
2.76
2.48
g/l
0.33
143
1013
870
8392
2.03
3.93
31.1
24.9
254.50
251.72
e9/l
0.63
851
8228
870
8394
2.03
3.90
30.9
24.8
91.34
91.27
fl
0.17
858
8304
870
8397
2.02
3.85
31.0
24.9
4.46
4.46
e12/l
0.02
847
8207
853
8184
1.78
3.83
15.6
12.4
24.58
25.68
u/l
1.59
831
7940
503
4431
1.31
3.78
7.3
6.7
10.38
11.24
umol/l
1.77
476
4222
870
8401
2.00
3.78
31.2
25.0
134.30
134.20
g/l
0.08
859
8309
31
148
2.13
3.72
1.7
1.4
131.44
159.42
au/ml
—
9
46
101
687
1.53
3.71
3.9
4.1
1.24
1.23
mmol/l
1.24
90
594
869
8397
1.95
3.62
31.6
25.3
40.36
40.11
%
0.96
855
8301
167
1261
1.40
3.58
1.6
1.5
—
—
—
0
0
154
1149
1.41
3.54
7.0
5.2
1.05
1.03
mmol/l
0.24
145
1065
163
1229
1.40
3.52
2.7
2.5
24.19
22.53
%
0.73
151
1153
13
36
3.65
3.50
1.2
1.5
171.69
155.74
mmol/24h
0.33
13
36
350
2960
1.30
3.50
3.6
3.4
6.96
7.26
mmol/l
0.64
292
2512
516
4596
1.29
3.41
3.0
2.8
—
—
—
0
0
185
1432
1.37
3.41
2.7
2.5
13.74
12.87
umol/l
0.93
176
1338
319
2673
1.30
3.40
3.1
2.6
53.39
93.42
u/l
0.74
295
2473
438
3824
1.28
3.38
2.8
2.8
—
—
estimate
—
0
0
12
33
3.67
3.30
1.0
1.1
1529.58
1796.09
miu/ml
0.47
12
33
216
1723
1.33
3.26
3.0
2.9
2.46
2.46
mmol/l
0.01
201
1551
796
7560
1.45
3.23
20.9
15.8
77.70
79.55
ml/min/173m2
1.84
744
7007
432
3790
1.27
3.12
3.0
2.5
80.58
78.61
nmol/l
0.73
397
3402
49
293
1.71
3.07
1.6
1.6
42.52
13.26
u/ml
—
6
57
13
41
3.20
3.06
2.7
3.6
847.54
720.76
u/ml
0.11
13
41
182
1433
1.34
2.99
1.4
1.3
3.80
12.43
u/ml
3.60
65
545
74
495
1.54
2.97
3.3
3.4
4.42
4.57
pmol/l
0.76
67
438
97
687
1.46
2.96
3.3
2.4
0.22
0.55
e6/l
1.25
97
655
221
1795
1.31
2.91
1.7
1.7
0.89
1.22
mg/l
2.88
178
1406
184
1457
1.33
2.90
3.6
3.3
0.81
0.82
mmol/l
0.45
174
1382
57
361
1.62
2.89
2.9
2.3
41.73
39.28
u/l
0.48
52
318
234
1923
1.29
2.81
5.8
4.1
1.02
1.02
kg/l
0.27
153
1289
31
166
1.90
2.79
2.5
3.6
7.01
9.10
pmol/l
1.14
31
166
110
809
1.41
2.75
3.1
2.1
329.73
380.12
nmol/l
2.40
104
758
21
98
2.17
2.72
1.7
1.3
—
—
—
0
0
10
30
3.36
2.60
4.2
2.7
0.57
0.61
mmol/l
—
10
30
19
88
2.18
2.52
1.2
1.3
—
—
—
0
0
42
256
1.67
2.50
1.8
1.5
0.01
0.09
iu/ml
—
8
41
332
2890
1.24
2.40
4.3
4.1
6.21
7.78
mg/mmol
0.41
201
1788
272
2317
1.25
2.39
4.1
3.5
0.13
0.01
estimate
0.59
99
722
29
161
1.83
2.37
1.3
1.2
231.65
256.24
u/ml
0.26
20
89
20
98
2.06
2.33
1.5
1.4
32.07
27.33
u/l
0.25
15
83
677
6363
1.26
2.30
25.7
21.3
331.36
331.66
g/l
0.38
672
6332
419
3748
1.22
2.30
2.3
2.1
92.28
96.88
pmol/l
1.37
221
1935
124
960
1.34
2.28
8.1
6.7
—
—
—
0
0
19
93
2.07
2.22
1.1
1.2
—
—
—
0
0
35
212
1.68
2.16
1.6
2.3
130.52
127.96
g/l
0.25
27
171
572
5297
1.22
2.15
3.8
3.4
45.43
48.96
u/l
0.37
527
4954
9
30
3.02
2.15
3.6
4.9
—
—
—
0
0
159
1288
1.28
2.12
1.4
1.4
—
—
—
0
0
15
69
2.19
2.05
2.2
2.7
1122.33
934.59
mg
0.14
15
69
84
630
1.37
1.92
1.7
1.4
—
—
—
0
0
107
835
1.32
1.89
3.7
3.4
—
—
—
0
0
105
824
1.31
1.79
5.2
3.4
1.99
1.92
mmol/l
0.07
92
701
40
265
1.53
1.76
1.3
1.3
—
—
—
0
0
8
30
2.68
1.72
2.0
1.2
—
—
—
0
0
13
62
2.11
1.66
1.5
1.4
—
391.25
—
0
8
678
6452
1.20
1.64
24.5
20.4
13.72
13.66
%
0.64
670
6373
166
1396
1.23
1.62
1.9
1.7
1282.49
1184.10
nmol/l
0.66
131
1054
41
280
1.49
1.59
1.9
2.9
—
—
—
0
0
20
114
1.77
1.57
1.2
1.2
—
0.46
nmol/l
—
0
7
38
258
1.49
1.53
2.1
1.6
—
—
—
0
0
5
15
3.35
1.52
1.8
1.1
81.40
101.27
%
—
5
15
35
235
1.51
1.49
1.8
1.9
93.49
91.91
%
0.17
35
230
66
501
1.34
1.45
3.2
3.3
1.50
1.95
mmol/l
0.41
47
373
50
363
1.40
1.44
2.9
2.0
9.21
9.57
iu/ml
0.03
17
83
54
398
1.38
1.42
1.1
1.0
—
—
—
0
0
49
356
1.40
1.41
1.8
1.9
1.70
2.43
ug/l
0.26
44
318
121
1004
1.24
1.35
2.0
1.9
—
—
—
0
0
127
1060
1.23
1.34
1.9
1.8
—
—
—
0
0
10
47
2.14
1.34
1.0
1.1
—
—
—
0
0
9
42
2.15
1.34
1.0
1.1
—
—
—
0
0
22
136
1.63
1.33
4.1
3.7
1.11
1.18
%
0.06
22
124
101
823
1.26
1.32
3.4
2.3
0.21
0.21
g/l
0.16
95
765
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
24
2.51
1.30
1.7
2.1
120.17
124.96
%
—
6
24
165
1419
1.20
1.30
3.3
2.9
1.02
1.08
e6/l
0.06
99
744
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
14
77
1.83
1.26
1.4
1.3
637702.14
185027.91
e6/l
—
7
53
117
978
1.23
1.23
6.5
8.1
5.08
5.13
kpa
0.34
109
945
117
979
1.22
1.22
6.5
8.1
13.20
12.17
kpa
1.10
109
948
115
961
1.23
1.21
6.6
8.2
0.55
0.99
mmol/l
0.57
91
802
5
19
2.64
1.21
2.8
3.7
4.06
4.87
kpa
—
5
19
5
19
2.64
1.21
2.8
3.7
13.94
9.67
kpa
—
5
19
50
376
1.35
1.20
1.7
1.8
1.60
1.51
g/l
0.28
45
342
162
1405
1.19
1.17
2.1
1.9
—
—
—
0
0
33
233
1.43
1.14
1.5
1.6
—
—
—
0
0
84
684
1.25
1.13
2.6
2.3
12.65
7.36
ug/l
0.45
75
604
31
217
1.44
1.12
2.0
1.6
9514.33
12334.55
e6/l
0.26
21
151
230
2059
1.16
1.12
5.3
4.0
92.03
90.47
%
0.39
224
2018
30
209
1.45
1.12
1.2
1.3
607.60
541.23
mg/l
0.21
30
197
22
144
1.54
1.09
1.2
1.3
—
—
—
0
0
114
964
1.21
1.09
3.5
2.8
9.14
7.74
umol/l
0.26
96
856
193
1709
1.16
1.09
5.0
4.5
23.68
21.27
%
1.15
96
828
63
500
1.28
1.06
5.7
3.4
23.62
24.28
mmol/l
0.85
63
492
31
221
1.42
1.04
2.5
1.8
2.29
4.59
iu/l
2.17
15
88
236
2131
1.15
1.02
5.9
5.6
2.17
2.57
ug/l
0.73
218
1909
65
523
1.26
0.99
1.6
1.7
—
—
—
0
0
5
23
2.18
0.98
4.4
1.8
164.40
70.30
nmol/24h
—
5
23
6
27
2.23
0.93
2.3
1.2
—
—
—
0
0
35
261
1.35
0.92
2.5
3.1
1.89
3.58
ratio
0.55
27
143
144
1264
1.17
0.92
3.5
3.3
0.81
0.79
ug/l
0.06
102
818
16
243
0.65
0.91
1.1
1.2
1.52
1.58
g/l
0.39
16
243
10
56
1.79
0.88
2.2
2.0
24.10
21.23
nmol/l
—
10
51
6
30
2.01
0.87
1.2
1.5
—
—
—
0
0
18
120
1.51
0.86
1.2
1.1
0.79
1.91
u/ml
0.99
12
60
18
120
1.51
0.86
2.0
2.1
33.06
32.47
pg
0.31
18
120
145
1282
1.16
0.85
1.8
2.0
29.49
29.44
s
0.04
140
1252
13
80
1.63
0.85
1.9
1.7
—
—
—
0
0
45
355
1.28
0.83
1.3
1.4
32.43
29.94
iu/l
0.21
40
298
8
46
1.75
0.82
2.0
1.5
71.75
82.52
umol/l
—
8
46
16
105
1.53
0.82
2.8
1.8
—
—
—
0
0
177
1592
1.14
0.82
4.0
3.9
280.44
427.36
ng/l
0.50
132
1256
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
241
1.34
0.81
2.5
2.5
0.26
0.36
iu/ml
0.88
13
134
13
81
1.61
0.81
1.0
1.2
—
—
—
0
0
25
181
1.39
0.80
1.3
1.3
701.00
796.26
e6/l
0.04
20
134
67
557
1.22
0.80
1.1
1.2
76.72
135.29
u/ml
1.30
22
219
12
74
1.63
0.78
1.0
1.1
88.75
107.91
pmol/l
0.72
12
74
76
642
1.20
0.77
2.0
2.0
—
—
—
0
0
29
217
1.35
0.77
1.1
1.1
—
—
—
0
0
100
867
1.17
0.76
1.8
1.8
1.51
1.51
%
0.04
88
754
15
99
1.52
0.76
4.4
3.8
—
—
—
0
0
29
218
1.34
0.76
1.1
1.1
—
—
—
0
0
14
91
1.55
0.75
2.2
3.8
61.81
52.24
u/ml
0.10
14
91
192
1746
1.13
0.75
1.8
1.7
35032291.66
39160793.03
pmol/l
0.04
157
1453
69
581
1.20
0.73
2.1
1.9
—
—
—
0
0
221
2031
1.12
0.72
2.6
2.4
—
—
—
0
0
106
928
1.16
0.72
4.3
4.4
8.98
28.54
ug/l
1.22
88
765
7
39
1.80
0.72
2.1
1.8
41.16
41.51
g/l
—
7
39
10
60
1.67
0.72
1.8
1.3
—
—
—
0
0
31
238
1.31
0.71
1.0
1.2
—
—
—
0
0
7
41
1.71
0.70
4.0
5.0
—
126.29
—
0
7
13
85
1.54
0.69
5.0
3.7
60.35
55.21
%
0.47
13
77
10
61
1.65
0.68
1.8
1.3
—
—
—
0
0
11
69
1.60
0.68
1.0
1.1
—
—
—
0
0
11
69
1.60
0.68
1.0
1.1
—
—
—
0
0
24
179
1.35
0.67
1.2
1.3
26.11
47.70
e6/l
0.26
19
128
13
86
1.52
0.66
1.1
1.2
—
—
—
0
0
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
11
71
1.56
0.62
1.0
1.1
—
—
—
0
0
265
2479
1.10
0.62
1.8
1.7
20.51
20.42
nmol/l
0.04
231
2086
6
104
0.57
0.62
1.2
1.6
—
—
—
0
0
24
182
1.33
0.62
1.5
1.4
—
—
—
0
0
5
30
1.67
0.61
3.2
1.2
6.86
8.21
ug/l
—
5
30
87
762
1.16
0.61
2.7
2.4
31.90
38.28
u/l
1.17
81
627
16
113
1.42
0.61
2.0
2.3
10.06
10.80
mmol/l
0.49
16
113
0
20
0.00
0.60
0.0
1.0
—
28.69
—
0
20
32
254
1.27
0.60
1.7
1.4
322.32
284.29
ug/g
0.40
20
150
72
623
1.17
0.59
3.2
3.1
229.72
206.03
ng/l
0.15
67
580
8
52
1.54
0.59
1.3
1.2
—
—
—
0
0
16
114
1.41
0.59
2.5
1.7
—
—
—
0
0
33
264
1.26
0.59
1.6
1.5
—
—
—
0
0
8
53
1.51
0.58
3.6
1.7
—
—
—
0
0
25
194
1.30
0.56
2.2
1.6
—
—
—
0
0
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
9
63
1.43
0.52
3.3
1.6
—
—
—
0
0
62
537
1.17
0.52
2.5
2.5
12.40
12.83
nmol/l
0.14
57
485
27
335
0.80
0.50
2.2
1.6
0.25
0.33
mg/l
0.59
13
145
27
216
1.26
0.50
2.9
3.3
2.91
2.24
index
0.20
11
119
7
108
0.65
0.49
1.0
1.1
—
—
—
0
0
14
189
0.74
0.48
1.0
1.6
0.70
0.84
nmol/l
—
9
158
10
68
1.48
0.47
1.2
1.2
—
—
—
0
0
7
48
1.46
0.47
1.1
1.2
14.57
17.05
u/l
—
7
39
69
610
1.14
0.46
1.8
1.6
—
—
—
0
0
30
246
1.23
0.46
1.1
1.3
—
—
—
0
0
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
14
103
1.36
0.45
1.5
1.4
0.63
0.32
nmol/l
—
9
78
7
50
1.40
0.45
1.1
1.2
47.86
76.69
u/l
—
7
42
7
50
1.40
0.45
1.0
1.5
—
—
—
0
0
7
51
1.38
0.44
1.1
1.3
—
—
—
0
0
7
51
1.38
0.44
1.3
1.3
—
—
—
0
0
11
78
1.42
0.43
1.0
1.1
—
—
—
0
0
5
31
1.62
0.43
1.6
3.2
—
74227.17
—
0
6
5
31
1.62
0.43
1.4
1.5
—
—
—
0
0
8
56
1.43
0.42
3.6
1.6
—
—
—
0
0
8
56
1.43
0.42
1.8
1.4
10.50
13.84
u/l
—
8
51
10
139
0.72
0.42
1.8
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
28.03
—
0
11
5
34
1.47
0.40
1.8
1.5
—
—
—
0
0
50
437
1.15
0.40
1.9
1.4
—
—
—
0
0
21
257
0.81
0.37
1.9
1.2
0.90
0.89
g/l
0.04
21
257
9
69
1.31
0.37
3.4
1.8
—
—
—
0
0
23
189
1.22
0.36
2.8
2.5
99.19
100.57
ug/min
0.01
13
119
9
71
1.27
0.36
1.0
1.0
—
—
—
0
0
14
109
1.29
0.33
1.1
1.1
—
—
—
0
0
33
286
1.16
0.31
2.5
1.9
7.46
4.16
mg/l
0.45
27
222
20
165
1.22
0.31
2.5
1.6
—
—
—
0
0
22
184
1.20
0.30
2.0
2.0
8104.73
5490.29
u/l
—
6
78
25
293
0.85
0.30
3.0
1.7
—
—
—
0
0
74
806
0.91
0.30
2.2
2.0
3.74
3.39
ratio
1.08
55
629
10
75
1.34
0.30
1.2
1.3
—
—
—
0
0
27
231
1.17
0.30
1.7
1.4
—
—
—
0
0
18
148
1.22
0.29
2.4
1.9
—
—
—
0
0
8
110
0.72
0.29
1.1
1.1
—
1.75
—
0
18
139
1316
1.07
0.27
3.3
3.1
2.26
2.52
e6/l
0.13
71
644
5
71
0.70
0.26
1.4
1.6
—
—
—
0
0
5
71
0.70
0.26
1.4
1.6
—
—
—
0
0
5
71
0.70
0.26
1.4
1.6
—
—
—
0
0
18
212
0.85
0.24
1.5
1.2
—
—
—
0
0
14
115
1.22
0.23
1.1
1.2
1.13
2.58
u/ml
—
8
36
353
3442
1.04
0.23
2.1
2.0
1.36
1.34
mmol/l
0.19
278
2888
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
55
596
0.92
0.22
2.0
1.7
3.61
3.44
mmol/l
0.34
37
421
15
178
0.84
0.22
2.9
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
7.1
—
—
—
0
0
16
188
0.85
0.21
1.1
1.1
—
3.90
—
0
23
23
201
1.15
0.21
1.4
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
283
2756
1.04
0.20
4.2
3.3
30.90
32.14
u/l
0.33
270
2611
6
50
1.20
0.19
1.0
1.2
—
—
—
0
0
6
52
1.15
0.19
1.3
2.0
—
—
—
0
0
40
368
1.09
0.17
1.3
1.4
—
—
—
0
0
13
110
1.18
0.17
1.0
1.4
—
—
—
0
0
13
110
1.18
0.17
1.0
1.4
—
—
—
0
0
10
82
1.22
0.17
1.0
1.1
101.40
93.29
%
—
10
77
5
70
0.71
0.16
1.8
2.1
—
—
—
0
0
10
120
0.83
0.16
1.0
1.1
—
—
—
0
0
12
101
1.19
0.16
1.8
2.6
20.60
26.05
mg/l
—
5
42
18
158
1.14
0.16
1.4
1.4
—
—
—
0
0
18
158
1.14
0.16
1.4
1.4
—
—
—
0
0
13
111
1.17
0.16
1.0
1.4
—
—
—
0
0
16
141
1.14
0.14
2.6
1.6
—
—
—
0
0
18
161
1.12
0.13
1.5
2.0
175.39
212.64
pmol/l
0.93
18
150
5
45
1.11
0.10
4.2
3.2
0.80
1.12
%
—
5
45
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
26
242
1.08
0.09
3.5
1.8
0.00
0.00
g/l
-0.00
26
232
6
57
1.05
0.08
1.7
1.7
83.52
100.41
ng/l
—
6
57
13
117
1.11
0.08
1.0
1.4
—
—
—
0
0
13
117
1.11
0.08
1.0
1.4
—
—
—
0
0
36
342
1.05
0.08
2.6
1.8
—
—
—
0
0
6
74
0.81
0.07
1.3
1.6
43.54
52.16
ug/l
—
6
74
7
82
0.85
0.07
1.1
2.0
—
—
—
0
0
30
316
0.95
0.07
2.4
1.9
—
—
—
0
0
22
206
1.07
0.07
1.9
1.9
59.82
40.05
nmol/l
1.15
22
197
9
88
1.02
0.07
1.6
1.8
—
—
—
0
0
25
238
1.05
0.05
1.3
1.3
183.43
243.37
miu/ml
0.36
14
106
22
209
1.05
0.04
1.2
1.4
70.41
259.32
pmol/l
1.59
22
204
10
91
1.10
0.04
1.1
1.9
—
—
—
0
0
24
230
1.04
0.03
1.7
1.3
—
—
—
0
0
28
290
0.96
0.03
1.3
1.4
—
—
—
0
0
30
291
1.03
0.02
2.0
1.8
—
—
—
0
0
11
117
0.94
0.01
1.7
1.5
—
—
—
0
0
103
1038
0.99
0.01
5.5
5.0
30.24
32.56
%
1.56
72
690
11
116
0.95
0.00
1.1
1.2
3.80
6.50
u/ml
—
5
52
13
124
1.05
0.00
1.1
1.1
—
1.03
—
0
7
23
224
1.03
0.00
2.3
1.7
—
—
—
0
0
22
216
1.02
0.00
2.4
1.7
—
—
—
0
0
17
172
0.99
0.00
2.6
1.6
—
—
—
0
0
11
111
0.99
0.00
1.6
1.5
0.71
1.29
ratio
—
6
68
11
111
0.99
0.00
1.6
1.5
0.81
1.20
ratio
—
6
68
11
111
0.99
0.00
1.6
1.5
1.14
0.95
ratio
—
6
68
12
115
1.04
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
73.86
—
0
7
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
9
98
0.92
-0.00
2.1
2.7
1.18
1.20
mmol/l
—
9
98
8
88
0.91
-0.00
1.4
1.4
—
—
—
0
0
9
99
0.91
-0.00
2.1
2.7
104.11
105.36
mmol/l
—
9
99
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.4
—
0.67
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.5
1.50
3.45
ug/l
—
5
43
7
76
0.92
-0.00
1.3
1.1
—
—
—
0
0
11
110
1.00
-0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
50.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
80
1.00
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
6.30
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint H7_CONJUVASC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUVASC | 0.92 [0.81, 1.05] | 0.219 |
| Birth year | 0.994 [0.99, 1.0] | 0.16 |
During the follow-up period (1.1.1998 — 31.12.2019), 359 out of 2876 females with H7_CONJUVASC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUVASC | 0.928 [0.81, 1.06] | 0.266 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 388 out of 2074 males with H7_CONJUVASC died.
Mortality risk
Mortality risk for people of age
years, who have H7_CONJUVASC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.071% | 0.187% |
| 5 | 0.519% | 1.012% |
| 10 | 1.248% | 2.506% |
| 15 | 2.497% | 4.787% |
| 20 | 4.41% | 8.114% |
Relationships between endpoints
↥Index endpoint: H7_CONJUVASC – Other conjunctival vascular disorders and cysts
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data